Andrew C. Weiss
Investor Relations Contact bij IDORSIA LTD
Profiel
Andrew C.
Weiss currently works at Idorsia Ltd., as SVP, Head-Corporate Communication & IR from 2017.
Mr. Weiss also formerly worked at Actelion Ltd., as Senior Vice President from 2014 to 2017, Bank Vontobel AG (Research Firm), as Head of Life Sciences Team, Bank Sarasin & Cie AG (Broker), as Research Analyst, and Julius Baer Holding AG, as Fund Manager from 2000 to 2005.
Mr. Weiss received his graduate degree from the University of Zurich.
Actieve functies van Andrew C. Weiss
Bedrijven | Functie | Begin |
---|---|---|
IDORSIA LTD | Investor Relations Contact | 01-06-2017 |
Eerdere bekende functies van Andrew C. Weiss
Bedrijven | Functie | Einde |
---|---|---|
ACTELION | Investor Relations Contact | 01-01-2017 |
Bank Sarasin & Cie AG (Broker) | Analyst-Equity | 01-05-2007 |
Julius Baer Holding AG | Corporate Officer/Principal | 01-01-2005 |
Bank Vontobel AG (Research Firm) | Analyst-Equity | - |
Opleiding van Andrew C. Weiss
University of Zurich | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
IDORSIA LTD | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
Bank Vontobel AG (Research Firm) | Finance |
Bank Sarasin & Cie AG (Broker) | Finance |
Julius Baer Holding AG | Finance |